dr. borst on homologous recombination deficiency in patients with ovarian cancer
Published 6 years ago • 464 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
6:08
treating ovarian cancer based on hrd status
-
45:27
what is hrd (homologous recombination deficiency) and how does it impact ovarian cancer?
-
3:51
treating homologous recombination proficient ovarian cancer
-
6:28
ovarian cancer: what is the role of hrd testing?
-
1:11
dr. rana on genetic testing guidelines for patients with ovarian cancer
-
8:41
impact of hrd status on frontline treatment of ovarian cancer
-
3:46
illumina oncology - homologous recombination deficiency (hrd) testing in ovarian cancer
-
3:46
introduction to homologous recombination deficiency (hrd) assessment
-
2:23
dr. moore on unanswered questions with parp inhibitors in ovarian cancer
-
4:39
molecular testing in ovarian cancer
-
1:36
jerry lanchbury, phd, describes myriad's hrd test
-
12:05
the rationale for hrd genomic instability testing in patients with advanced ovarian cancer
-
4:42
treatment of hrd-negative ovarian cancer
-
0:42
dr. zsiros discusses pembrolizumab triplet in recurrent ovarian cancer
-
4:51
homologous recombination deficiency and cancer care
-
44:10
next-generation sequencing (ngs) assessment of homologous recombination deficiency (hrd)...
-
0:59
dr. campos on next steps with parp inhibitors in ovarian cancer
-
36:43
homologous recombination deficiency (hrd) in tumors presented by dr. maher albitar
-
0:52
the importance of hrd testing in ovarian cancer